Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 146Leukemia 49Precursor Cell Lymphoblastic Leukemia-Lymphoma 46Congenital Abnormalities 30Myelodysplastic Syndromes 25Leukemia, Monocytic, Acute 23Recurrence 22Leukemia, Myelomonocytic, Acute 22Leukemia, Erythroblastic, Acute 20Leukemia, Megakaryoblastic, Acute 19Lymphoma 17Leukemia, Biphenotypic, Acute 13Lymphoma, Non-Hodgkin 12Burkitt Lymphoma 12Lymphoma, Large B-Cell, Diffuse 11Leukemia, Myelomonocytic, Chronic 11Blast Crisis 11Lymphoma, Mantle-Cell 9Leukemia, Lymphocytic, Chronic, B-Cell 9Lymphoma, Follicular 8Lymphoma, Large-Cell, Immunoblastic 7Leukemia, Eosinophilic, Acute 7Leukemia, Basophilic, Acute 7Myeloproliferative Disorders 6Lymphoma, B-Cell, Marginal Zone 6Hodgkin Disease 6Hematologic Neoplasms 6Myelodysplastic-Myeloproliferative Diseases 5Leukemia, Promyelocytic, Acute 5Leukemia, Myeloid, Accelerated Phase 5

Interventions

dexamethasone acetate 1dexamethasone 21-phosphate 1asparaginase erwinia chrysanthemi recombinant 1Vincristine 1Methotrexate 1Doxorubicin 1Dexrazoxane 1Dexamethasone 1Cytarabine 1Calcium Dobesilate 1Asparaginase 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Hypersensitivity × Cytarabine × Clear all
NCT00928200 2019-02-19

Erwinase for Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (IND 104224)

Therapeutic Advances in Childhood Leukemia Consortium

Phase 1 Terminated
1 enrolled 7 charts
LymphoidOther hematologic neoplasm

Hypersensitivity, Leukemia, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡